Department of Gastroenterology, Hepatology and Infectious Diseases, University Hospital, Düsseldorf, Medical Faculty of Heinrich Heine University Düsseldorf, Düsseldorf.
Department of Internal Medicine II, Marien-Hospital, 46483, Wesel, Germany.
J Clin Gastroenterol. 2024 Aug 1;58(7):640-649. doi: 10.1097/MCG.0000000000001918.
Mallory-Weiss syndrome (MWS) is a rare cause of upper gastrointestinal bleeding from gaging or vomiting-induced mucosal lacerations at the gastroesophageal junction. Most cases do not require urgent endoscopic intervention due to the mostly self-limiting course. For more severe cases, different hemostasis techniques have been used. In small MWS cohorts, overall mortality was ~5%, but comprehensive data, as well as population-based incidence, treatment recommendations, and outcome parameters such as in-hospital mortality and adverse events, are largely lacking.
We evaluated current epidemiological trends, therapeutic strategies, and in-hospital Mortality of MWS in Germany based on standardized hospital discharge data provided by the German Federal Statistical Office from 2010 to 2019.
A total of 59,291 MWS cases, predominately male (62%), were included into analysis. The mean number of MWS cases in Germany was 5929/year and decreased continuously during the observation period (-4.1%/y). The overall annual incidence rate (as hospitalization cases per 100,000 persons) was 7.5 with the highest incidence rate in the New Federal States (8.7). The most common comorbidities were reflux esophagitis (23.6%), diaphragmatic hernia (19.7%), and alcohol abuse (10.9%). The most frequent complication was bleeding anemia (26%), whereas hypovolemic shock (2.9%) was rare. Endoscopic injection was the most commonly performed endoscopic therapy (13.7%), followed by endoscopic clipping (12.8%), whereas the need for surgical therapy was rare (0.1%). Endoscopic combination therapies were used predominantly as a combination of injection and clipping. The overall in-hospital mortality was 2.7% and did not differ through the observation period. The presence of hypovolemic shock, acute kidney injury, sepsis, artificial ventilation, adult respiratory distress syndrome, bleeding anemia, and female sex was associated with a significantly worse prognosis.
Our study gives a detailed insight into the incidence, patient-related risk factors, endoscopic treatment, and overall in-hospital mortality as well as regional differences in a large MWS collective in Germany. Furthermore, we were able to identify mortality-associated complications and their impact.
Mallory-Weiss 综合征(MWS)是一种罕见的上消化道出血原因,由食管胃连接处的呕吐或呕血引起的黏膜撕裂引起。由于大多数情况下病情自限,大多数病例不需要紧急内镜干预。对于更严重的病例,已经使用了不同的止血技术。在较小的 MWS 队列中,总体死亡率约为 5%,但缺乏全面的数据以及基于人群的发病率、治疗建议和住院死亡率和不良事件等预后参数。
我们根据德国联邦统计局 2010 年至 2019 年提供的标准化住院数据,评估了德国当前的流行病学趋势、治疗策略和 Mallory-Weiss 综合征的住院死亡率。
共纳入 59291 例 MWS 病例,主要为男性(62%)。德国每年 MWS 病例数平均为 5929 例,在观察期间呈持续下降趋势(-4.1%/年)。总体年发病率(每 10 万人住院人数)为 7.5,新联邦州的发病率最高(8.7)。最常见的合并症是反流性食管炎(23.6%)、膈疝(19.7%)和酒精滥用(10.9%)。最常见的并发症是出血性贫血(26%),而低血容量性休克(2.9%)则很少见。内镜注射是最常用的内镜治疗方法(13.7%),其次是内镜夹闭(12.8%),而手术治疗则很少见(0.1%)。内镜联合治疗主要是注射和夹闭的联合治疗。总体住院死亡率为 2.7%,在观察期间没有差异。低血容量性休克、急性肾损伤、败血症、人工通气、成人呼吸窘迫综合征、出血性贫血和女性与预后显著恶化相关。
本研究详细了解了德国一个大型 MWS 队列的发病率、患者相关危险因素、内镜治疗和总体住院死亡率以及区域差异。此外,我们还能够确定与死亡率相关的并发症及其影响。